The prevalence of secondary bacterial infection among hospitalized patients with covid-19 in Basra Iraq

Abstract

Purpose: sever ill (COVID-19) patients need admission to hospital leads to an increased risk of secondary bacterial infections. our study considers reports on the predominance of Secondary bacterial infection (SIs) profiles and clinical outcomes of Covid-19 hospitalized patients in Iraq.

Patients and strategies: this is a cross-sectional investigation, two healing clinics in Iraqi Basra were used to study secondary bacterial infections in covid-19 patients between September and November 2021.

Demographic characteristics of microorganisms, antimicrobial resistance, and clinical outcomes of the admitted COVID-19 patients were gathered.

Results: _ A total of 33 patients were admitted, (19\33, 57.6%) patients created a secondary bacterial infection. The mortality rate among patients who acquired secondary infections was 21% against overall death of 12.12% in total admitted COVID-19 patients. Gram-negative bacteria are the most common microorganism 52.6%, Klebsiella pneumonia (31.6%) was the transcendent pathogen, followed by streptococcus pneumonia (26.32%). High third-generation cephalosporin resistance was seen in Klebsiella pneumonia (83%), followed by aminoglycoside at 33% and carbapenem resistance at 16.7%.

Conclusion: _ The prevalence of Gram-negative pathogens in COVID-19 patients related to the tall level of bacterial resistance to antimicrobials may be a caution found. Patients with secondary bacterial infections in Covid-19 had a significant mortality rate. leads to an important point to improve infection control practice to spare patients' lives and avoid drug-resistant infection.